Hervolution receives 2.5M EUR in funding through the European Innovation Council Accelerator

15 Oct 2021
By Hervolution

We are beyond proud to announce that Hervolution is one of just 65 European companies to receive funding through the European Innovation Council Accelerator. Being selected among more than 4000 applicants, the funding of €2.5m

Related news

News

Steven Glazer joins Hervolution as Medical Advisor

24 Jun 2019

By Hervolution

News

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, Hervolution for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)

05 Feb 2020

By Hervolution

News

Hervolution attracts profile from NIH: Emeline Ragonnaud reunites with Peter J. Holst after 3 years

19 Jun 2020

By Hervolution

News

Hervolution announces EUR 6M Seed financing with the participation of the European Innovation Council Fund to develop first-in-class cancer immunotherapy

24 May 2023

By Hervolution